Carboxypeptidase-G2 in Treating Nervous System Toxic Effects in Patients Given an Overdose of Intrathecal Methotrexate

Mise à jour : Il y a 4 ans
Référence : NCT00018967

Femme et Homme

Extrait

RATIONALE: Chemoprotective drugs such as carboxypeptidase-G2 may protect normal cells from the toxic effects of chemotherapy. PURPOSE: Clinical trial to study the effectiveness of carboxypeptidase-G2 in treating nervous system toxic effects in patients given an accidental overdose of intrathecal methotrexate.


Critère d'inclusion

  • Neurotoxicity ,Unspecified Adult Solid Tumor, Protocol Specific ,Unspecified Childhood Solid Tumor, Protocol Specific


Liens